Carboxyl Terminus of Bovine Papillomavirus Type-1 L1 Protein Is Not Required for Capsid Formation  by Paintsil, Jeanette et al.
VIROLOGY 223, 238–244 (1996)
ARTICLE NO. 0473
SHORT COMMUNICATION
Carboxyl Terminus of Bovine Papillomavirus Type-1 L1 Protein
Is Not Required for Capsid Formation
JEANETTE PAINTSIL,* MARTIN MU¨LLER,† MARIA PICKEN,‡ LUTZ GISSMANN,† and JIAN ZHOU†,1
*Department of Microbiology & Immunology, †Department of Obstetrics & Gynecology, and ‡Department of Pathology,
Loyola University Medical Center, 2160 South First Avenue, Maywood, Illinois 60153
Received January 25, 1996; accepted July 2, 1996
The papillomavirus major capsid protein L1 can assemble into capsids in vitro. To identify areas within the bovine
papillomavirus type-1 L1 (BPV L1) protein that are important for virus assembly, we constructed a set of 24 baculovirus
recombinants expressing BPV L1 deletion mutants that span the entire L1 open reading frame. Virus-like particle (VLP)
formation of the L1 mutants was examined by electron microscopy. Wild-type (wt) BPV L1 expressed in recombinant
baculovirus formed VLPs, while capsomeres and aggregates were seen for most of the mutants screened. However, the
C-terminal truncation mutant, lacking the last 24 amino acids (DC2), was observed to form VLPs (threefold more efficiently
than wt BPV L1). This suggests that this C-terminal region of L1 protein is not critical for capsid formation. As capsids
assembled from BPV L1 are able to agglutinate mouse red blood cells (RBC) by binding to a membrane protein, we tested
the ability of the mutants to hemagglutinate mouse RBCs. Most aberrant capsids or aggregates derived from deletion
mutants were unable to agglutinate the RBCs with the exception of deletion mutants D11 (aa 231–271), D14 (aa 291–
331), D21 (aa 431– 471), and the carboxyl-terminus truncation mutant DC2. q 1996 Academic Press, Inc.
Papillomaviruses (PVs) are small nonenveloped icosa- spanning the entire L1 open reading frame of 495 amino
acids (aa). Each deletion covers 40 amino acids with 20hedral DNA viruses with a double-stranded circular ge-
nome of about 8000 bp. PV particles measure about 55 of the amino acids overlapping the adjacent deletion.
In addition, an amino-terminal truncation mutant (DN,nm in diameter and have a buoyant density in CsCl of
1.34 g/ml and empty particles of about 1.29 g/ml (1). The missing aa 2–31) was generated. Two carboxyl-terminus
truncations, DC1 (aa 451–495) and DC2 (aa 471–495),mature PV has two capsid proteins encoded by nonover-
lapping open reading frames, the major L1 protein and were also constructed (Fig. 1).
The BPV L1 gene was amplified by PCR fromthe minor protein L2 (2, 3). Both structural proteins L1
(55 kDa) and L2 (50 kDa) contain nuclear localization pSXBPVL1 plasmid (9) using the following synthetic oli-
gonucleotide primers: 5*-GGGATCCATGGCGTTGTG-signals (NLS) for transport into the nucleus after synthe-
sis in the cytoplasm (4, 14). NLS are stretches of five to GCAACAAGGCCAGAAGCTG-3* (covering L1 nt 5608 to
5637) as 5* primer and 5*-CGGGATCCTTATTTTTTTTTT-seven basic amino acids composed mainly of the amino
acids arginine and lysine (5–7). The assembly of PV parti- TTTTTTGCAGGCTTACTGG-3* (covering L1 nt 7064 to
7095) as 3* primer. BamHI restriction enzyme recognitioncles occurs in the nucleus of infected cells (8).
A detailed study of PV capsid assembly is lacking as sites (underlined) were added to both primers. The start
and stop codons are in bold. PCR amplification was car-there is no suitable cell culture system for the propaga-
tion of PV particles. Previous studies have demonstrated ried out in 100 ml with 0.1 mg DNA as template, 20 mM
dNTPs, 5 mM KCl, and 2 u Taq DNA polymerase for 30that the PV L1 protein alone can self-assemble into virus-
like particles when expressed as a recombinant protein cycles at 957 for 2 min, 587 for 0.5 min, and 727 for 1 min.
The PCR fragment was purified through 1% agarose gel,using the vaccinia virus and baculovirus systems (9–
13). To identify functional domains of the papillomavirus digested with BamHI, and then cloned into the BamHI
site of a pUC-based plasmid (pUC4b) (4) to createmajor L1 protein we have constructed a series of 20
bovine papillomavirus type-1 (BPV) L1 deletion mutants pUC4b/BPVL1. The L1 deletion mutants were con-
structed by PCR mutagenesis of the L1 gene using
pUC4b/BPVL1 as template and a set of oligonucleotide1 To whom correspondence and reprint requests should be ad-
primers shown in Table 1, as previously described (14).dressed at Loyola University of Chicago Medical Center, Bldg. 105,
The EcoRV sites present on the primers are depicted inRoom 2890, 2160 South First Avenue, Maywood, IL 60153. Fax: (708)
216-1196. bold. These EcoRV sites encode 2 extra amino acids
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FIG. 1. Diagram of BPV L1 deletions. Schematic representation of the L1 deletions. Sequential deletions were generated by PCR mutagenesis
of the L1 gene. Each mutant had 40 amino acids deleted. The N- and C-termini truncation mutants are also shown. The full length L1 is shown at
the top. Numbers on the left indicate the exact sequences deleted. The names of the mutants are shown to the right of the deleted-aa sequences.
BPV L1 deletion mutants were constructed by polymerase chain reaction (PCR) mutagenesis of the L1 gene from pUC4b/BPVL1 plasmid using the
primers listed in Table 1. PCR fragments were purified through 1% agarose gel. The PCR fragments with new EcoRV sites were religated and the
DNAs were then used to transform E. coli DH5a. The clones were screened for EcoRV sites, and the L1 genes with deletion were analyzed by
agarose gel electrophoresis to confirm the deletion. HA, hemagglutination; EM, electron microscopy. Because of frameshift of D1 and failure in
cloning of D17, the HA and EM results are not available for these two mutants. The positions of point mutations introduced by PCR are indicated
with bars in each L1 ORF. The positions of point mutations are shown on the top of each bar (see also Table 2).
(Asp and Ile) which are inserted where 40 amino acids form Escherichia coli DH5a and the clones were
screened for EcoRV sites.are deleted in mutantsD1–D21. Each primer pair ampli-
fied pUC4b/BPV L1 in opposite directions, thereby delet- The mutated L1 fragments were then subcloned into
the BamHI site of the baculovirus transfer vector pVL1393ing DNA sequences encoding for 40 amino acids in the
region not covered by primer pairs and generating EcoRV (Invitrogen) to give pVLBPVL1/Dx–y (x–y denotes the
position of aa deleted). Plasmids pVLBPVL1/ND1-31 ,restriction sites. The PCR fragments were then digested
with EcoRV and religated. The DNA was used to trans- pVLBPVL1/C1D451-495 , and pVLBPVL1/C2D471-495 were con-
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TABLE 1 a Sequenase 2.0 kit (United States Biochemical Co.,
Cleveland, OH) using BPV L1-specific primers. The re-Sequences of the Oligonucleotide Primers Used to Construct BPV-1
sults are presented in Table 2. Sequencing of the wt L1L1 Deletion/Insertion Mutants
template (pSXBPVL1) used to generate mutants D1 to
aa deleted D21 revealed a nucleotide change at position 1453. This
Primer sequence
point mutation resulted in a threonine to alanine change
at amino acid position 486 in the C-terminus of L1. There-5* primers
D1 5*-CGCGATATCCAACTACCTGATCCCAATC 31– 71 fore, mutants derived from this L1 template have this
D2 5*-CGCGATATCGAGCGGCTGGTGTGGCCAG 51– 91 point mutation. This mutation was not found in wt and
D3 5*-CGCGATATCACTGTAACTGGGCACCCCAC 71– 111
DN using the template pUC4b/BPVL1. In DC1 and DC2D4 5*-CGCGATATCGTCACCACCCAAACAACAGATG 91– 131
D5 5*-CGCGATATCATTCTGTTGCTAGGCTGTACC 111 – 151 this region is deleted.
D6 5*-CGCGATATCGTTACTGATCGTCTAGAAAATGG 131 – 171 All the mutant constructs were expressed in insect
D7 5*-CGCGATATCGAAGATGGGGATATGATGG 151 – 191
cells using recombinant baculoviruses and tested forD8 5*-CGCGATATCAGTAAATCAGATCTACCTC 171 – 211
D9 5*-CGCGATATCAAAATGGCTGAGGACGCTGC 191 – 231
D10 5*-CGCGATATCTATGTTAGACACATCTGGACC 211 – 251
D11 5*-CGCGATATCTATTTAAAGAATAATAAAGG 231 – 271 TABLE 2
D12 5*-CGCGATATCCCCAGTGGCTCACTAGTCTC 251 – 291
D13 5*-CGCGATATCCGTGCCCAGGGCATGAAC 271 – 311 Point Mutations of BPVL1 ORF
D14 5*-CGCGATATCGACAATACACGTGGTACTAATC 291 – 331
D15 5*-CGCGATATCGAGTATGATAGCTCAAAATTC 311 – 351 Mutants nt aa change
D16 5*-CGCGATATCTTTATATTAGAGCTATGCTC 331 – 371
D17 5*-CGCGATATCCTTATGCCCTCTGTGCTTG 351 – 391 wt 136 T (C) 46 Tyr (His)
D18 5*-CGCGATATCTTAGAGGACACCTATCGC 371 – 411
664 G (A) 222 Asp (Asn)
D19 5*-CGCGATATCCCTGCAAAAGAAGACCCT 391 – 431
DN 340 G (A) 134 Ala (Thr)D20 5*-CGCGATATCCTTTCTTTGGACTTAGATC 411 – 451
451 G (C) 151 Asp (Gln)D21 5*-CGCGATATCGGATGTTCAACTGTGAGAAAACG 431 – 471
864 C (T) 288 His (His)3* primers
D1 5*-CGCGATATCGCTTTTTCTTTGCACATAGG 31– 71 D1 346 Deletion (C) Frameshift
D2 5*-CGCGATATCCACTGGGTAATATGGATGTCC 51– 91 1453 G (A) 485 Ala (Thr)
D3 5*-CGCGATATCTATTTTAAATACCCTATACTG 71– 111 D2 1453 G (A) 485 Ala (Thr)
D4 5*-CGCGATATCTTTACTTGGGTTGTGAACAGTC 91– 131 D3 154 C (T) 52 Pro (Ser)
D5 5*-CGCGATATCACCTCCAAGAGGCTGCCCTCTG 111 – 151 1256 C (T) 419 Ile (Ile)
D6 5*-CGCGATATCTTTTCTATTCACATTTTCTGC 131 – 171
1453 G (A) 485 Ala (Thr)
D7 5*-CGCGATATCCTGTTGTTGCTTAGCATCTAGG 151 – 191
D4 1453 G (A) 485 Ala (Thr)D8 5*-CGCGATATCACATGGACGGGCTGTTGTCC 171 – 211
D5 1453 G (A) 485 Ala (Thr)D9 5*-CGCGATATCTATGTGCTTGTTTTTTAATTC 191 – 231
D6 1453 G (A) 485 Ala (Thr)D10 5*-CGCGATATCTGCATTAATTTCTTTGAAGTTGG 211 – 251
D11 5*-CGCGATATCGAGGTAGTCTGGGTACAAGC 231 – 271 D7 1453 G (A) 485 Ala (Thr)
D12 5*-CGCGATATCCACCTGTTCTTTCCTTGC 251 – 291 D8 1453 G (A) 485 Ala (Thr)
D13 5*-CGCGATATCAAAATCTGTGGTAGGGGCTTC 271 – 311 D9 1453 G (A) 485 Ala (Thr)
D14 5*-CGCGATATCACTACCAAAATGCACACTGGG 291 – 331 D10 1453 G (A) 485 Ala (Thr)
D15 5*-CGCGATATCGAATAGCCAGTAGGGCCG 311 – 351 D11 656 G (A) 219 Gly (Asp)
D16 5*-CGCGATATCCCCCACTGTTAAAAACAATAAA 331 – 371
1453 G (A) 485 Ala (Thr)
D17 5*-CGCGATATCTGTTAGTGGGGTTCCATCTG 351 – 391
D12 1453 G (A) 485 Ala (Thr)D18 5*-CGCGATATCGGCTAGCTTATATTCTTCC 371 – 411
D13 1453 G (A) 485 Ala (Thr)D19 5*-CGCGATATCTCCTTGCAGATGTGACACAG 391 – 431
D14 749 G (A) 250 Arg (Gln)D20 5*-CGCGATATCTATCGATGAGGTAGGAGGCTG 411 – 451
D21 5*-CGCGATATCAATTACATTGCTTGCACATTTAG 431 – 471 1453 G (A) 485 Ala (Thr)
D15 154 G (T) 52 Ala (Ser)
1453 G (A) 485 Ala (Thr)Note. The primers were designed to create serial deletion mutants, each
missing DNA sequences encoding for 40 amino acids and overlapping D16 1453 G (A) 485 Ala (Thr)
D18 1453 G (A) 485 Ala (Thr)with neighboring 20 amino acids. The oligonucleotide sequences encoding
the L1 gene are indicated with the EcoRV sites in bold. The primer pairs D19 1453 G (A) 485 Ala (Thr)
D20 5 T (C) 2 Ala (Val)amplified in opposite directions to generate the deletions (see text).
1453 G (A) 485 Ala (Thr)
D21 30 C (T) 10 Pro (Leu)
1453 G (A) 485 Ala (Thr)structed by PCR amplification of the L1 gene from a
DC1 670 GA (AT) 224 Asp (Ile)BamHI-digested pUC4b/BPVL1 clone using primers
DC2 126 A (G) 42 Ala (Ala)
5*-GCGGATCCATGATTTTTTATCATGCAGAAACGG for 160 G (A) 54 Arg (Gly)
ND1-31 , 5*-CGGATCCTTACTTTTCTTTAAGATCTATGTT- 960 C (T) 320 Ile (Ile)
CC for CD451-495 , and 5*-GCGGATCCTTATGCCCCTTGC-
Note. The sites of the point mutations in the L1 ORF and protein areTGTGCTAAAAATC for CD471-495 . The amplified fragments
indicated by the nucleotide (nt) positions and amino acid (aa) positions.were then ligated into the BamHI site of pVL1393. A
The base exchanges and resultant alterations of the amino acids are
simplified name has been given for each deletion con- shown with the wild-type sequences in the parentheses. D1 construct
struct on the left side of Fig. 1. Dideoxy-chain termination has a deletion at nt 346 which results in frameshift and protein trunca-
tion.DNA sequencing of all L1 mutants was performed with
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FIG. 2. Immunoblotting of recombinant baculovirus BPV L1 deletions. Lysates from Sf9 insect cells infected with recombinant viruses were
separated by SDS–PAGE and electroblotted onto nitrocellulose filters. Proteins transferred onto nitrocellulose membranes were probed with a
1:2000 dilution of rabbit anti-BPV antibody (DAKO), followed by goat anti-rabbit peroxidase-conjugated secondary antibody (Sigma) at a 1:2000
dilution and detection by the enhanced chemiluminscence detection method (Amersham). Protein markers are shown on the left. The position of
the L1 protein (55 kDa) is indicated by the arrow on the right.
their abilities (i) to assemble into virus-like particles and sites removed (Fig. 2). In D2 and D3, D8 and D9, and
D15 and D16, one of these glycosylation sites is re-(ii) to agglutinate mouse erythrocytes. To express the
recombinant BPV L1 proteins, plasmid was used to co- moved but the upper bands are not affected. DC1 and
DC2 have the glycosylation sites intact but the 90-kDatransfect Sf9 insect cells with linearized Baculo-Gold
DNA (Pharmingen) using the calcium phosphate trans- bands were not observed. From these data we conclude
that the upper bands do not represent glycosylated formsfection method. For expression of PV capsid protein,
monolayers of Sf9 cells grown in TNM-FH insect medium of the L1 protein. It needs to be analyzed further whether
other forms of protein modification are responsible for(Sigma) at 277 were infected with the baculovirus recom-
binants. Infected cells were harvested 3 days later in the higher molecular weight L1 seen in the insect cells.
More C-terminal deletions of the L1 protein (from aa 475PBS. Lysates were centrifuged at 3000 g for 5 min and
the pellet was solubilized in SDS loading buffer. After to 493) did not produce this higher molecular weight L1.
Therefore, it is possible that production of the highersonication, each sample was analyzed by 10% SDS –
PAGE and visualized by Coomassie brilliant blue staining molecular form of L1 probably depends on a sequence
deleted in the C-terminus.and immunoblot assay.
Coomassie blue staining (data not shown) and immu- In order to determine the effects of mutations on parti-
cle assembly we screened the L1 deletion mutants fornoblot analysis (Fig. 2) showed that, with the exception
of D1, all proteins were made. Due to the deletions the their abilities to form virus-like particles (VLPs). Particles
present in the infected insect cells were purified by pel-mutant L1s had a lower molecular weight than wt L1 (55
kDa). The L1-specific bands were absent in the unin- leting through a 40% sucrose cushion and then subjected
to CsCl equilibrium density centrifugation. Following cen-fected and wild-type baculovirus-infected Sf9 cells. DNA
sequencing of D1 revealed a nucleotide deletion which trifugation, fractions were collected and analyzed by im-
munoblotting and detection of L1 protein using an antise-truncated the L1 protein at amino acid position 116 (Fig.
2; note the low molecular weight deletion product of rum against BPV-1 virions (DAKO). We found that after
CsCl centrifugation, wt BPV L1 and the L1 mutants wereabout 20 kDa ofD1). Figure 2 shows that there is hetero-
geneity within the mutants probably due to different present in fractions with a density corresponding to 1.27–
1.29 g/ml.amino acid composition. We also observed a slow mi-
grating L1 form of about 90 kDa. This band is missing in The immunoblot-positive CsCl fractions for each mu-
tant were dialyzed, mounted onto copper grids, nega-DC1 and DC2. The lower bands present in the lanes
may represent truncated L1 proteins or degradation tively stained with 2% uranyl acetate, and examined for
the presence of papillomavirus VLP structures. Electronproducts of the L1 proteins.
We have previously shown that the HPV-16 L1 protein microscope examination showed that the L1 mutants
formed capsomeres, aggregates, or irregular capsidsis partially glycosylated when expressed as recombinant
vaccinia virus (15). The BPV L1 protein N-glycosylation with the exception of DC2. The results are summarized
in Fig. 1. VLPs assembled from both the wt BPV L1 andsites (NXT/S) are present at amino acid positions 89, 210,
and 338. None of the L1 deletion mutants had all three the carboxyl-terminus truncation (DC2) missing the last
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FIG. 3. Electron micrograph of purified wild-type BPV L1 and VLPs assembled from truncated L1 proteins. Sf9 cells infected with recombinant
baculoviruses were harvested 3 days postinfection at 5000 g for 15 min, sonicated, and then cleared at 10,000 g for 8 min. The supernatant was
centrifuged through 40% sucrose cushion (20 mM HEPES [pH 7.3], 150 mM NaCl, 50 mM CaCl2 , 10 mM MgCl2) at 27,000 rpm for 2 hr. Particles
were purified by CsCl and fractions collected from the bottom. Samples were dialyzed against 1 mM HEPES for 30 min at room temperature. A 1:1
dilution in PBS was prepared and mounted onto carbon-coated copper grids (3 mm, 200 mesh size, EM Sciences) previously coated with poly-L-
lysine (1 mg/ml; Sigma). Grids were stained with 2% uranyl acetate and examined with a Zeiss EM 900 electron microscope at 80 kV. All the
electron micrographs were taken at the same magnification, and the bar in DC2 equals 100 nm.
24 amino acids of the L1 protein had the normal appear- that D3, D4, D7, D8, D9, D10, D12, D13, D15, D16,
D18, D19, and D20 formed irregular aggregates (Fig. 1).ance of an empty virus capsid of about 55 nm in size
(Fig. 3). Actual VLPs were produced by only the wild-type L1 and
DC2. DC2 produced VLPs with about threefold higherCapsomeres were present in the preparations of DN,
D2, D3, D4, D7, and DC1 (Fig. 1). The capsomeres efficiency compared to the wt BPV L1, as estimated when
SV40 full particles were used as internal standard inproduced by D2 had a different appearance, measured
about 10 nm in diameter, and were hollow inside (com- electron microscopy. This quantification was based on
the counting of more than 500 wt L1 and DC2 VLPs frompare with capsomeres in wt and DC2 particles in Fig.
3). Aberrant capsids of various dimensions and shapes 16 electron micrographs taken from different areas on
the grid.were formed by D6, D11 (depicted in figure 3), D5, D8,
D9, D14, D15, D21, and DC1 (see Fig. 1). We observed Immunofluorescence analysis of infected Sf9 cells
FIG. 4. Alignment of C-terminal sequences of L1 proteins. C-terminal sequences of 12 randomly selected PV L1 proteins using DNASTAR. Amino
acid numbers are shown on the left. Shaded areas represent identical amino acids. The C-terminal end of DC2 is indicated by the arrow.
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showed that DC2 was confined mainly to the cytoplasm structs with this point mutation (D1 through D21). We
intend to further characterize those L1 mutants that(data not shown), indicating that DC2 VLPs assembled
in the cytoplasm. Quantitative analysis of normalized wt formed some structures, like D2, D6, and DC1, and
those that retained the ability to hemagglutinate RBCL1 and DC2 L1 protein produced in the insect cells indi-
cated that DC2 formed VLPs with higher efficiency. DC2 (D11, D14,D21) by introducing smaller deletions. In this
way we may be able to delineate in detail the region(s)mutant with an added NLS which allowed nuclear trans-
portation as determined by immunofluorescence, also on L1 important for assembly.
The carboxyl-terminus truncation mutant DC2 lackingformed particles with similar efficiency (data not shown).
Therefore, it is unlikely that the difference between wt amino acids 471–495 assembled into VLPs, suggesting
that the deleted sequences are not critical for assembly.L1 and DC2 is due to differences in VLP recovery be-
cause of cellular location. To further confirm this observation we made seven more
serial C-terminal deletions between aa 475 and 493.The hemagglutination (HA) of mouse red blood cells
(RBCs) by BPV-1 has been documented by Favre et al. These truncation mutants formed VLPs as efficiently as
DC2 (data not shown), strongly suggesting that the C-(16) and recently by Roden et al. using VLPs (17). We
tested the ability of the purified mutant particles to agglu- terminal sequence is indeed not involved in capsid for-
mation. Further shortening of the L1 protein by anothertinate mouse RBCs. We found HA activity in wt VLPs,
but also in mutants D11, D14, D21, and DC2. The HA- 20 amino acids (DC1 451–495) abolished VLP formation
(Fig. 1). These truncation results suggested that deletionpositive mutants D11, D14, and D21 formed aberrant
capsids and thus maintained the L1 structure needed for of a more conserved region upstream of aa 471 (Fig. 4)
completely perturbs the proper folding of the L1 protein.HA activity (Fig. 1). The results suggest that the region
of L1 deleted in DC2 and these mutants is not involved Amino acid alignment of 12 sequenced PV L1 proteins
is shown in Fig. 4. With the exception of a cluster ofin binding to the RBCs.
In an attempt to gain insight into papillomavirus as- basic amino acids (K or R) and a short stretch of highly
conserved amino acids (aa 447–470 of BPV L1), the car-sembly mechanism we have investigated the L1 se-
quences required for VLP assembly by generating dele- boxyl end of the L1 sequence is the least conserved
region. The C-terminal truncation of DC2 just next to thetion mutants of BPV L1 protein. These mutant genes were
expressed by recombinant baculoviruses in insect cells. conserved region (Fig. 4) formed capsids, while the DC1
mutant missing this region failed to form capsids. TheseAlthough immunoblot analyses demonstrated the pres-
ence of L1 after CsCl purification, examination by elec- results suggest that this highly conserved sequence is
critical for capsid formation. The DC2 mutant has alsotron microscopy demonstrated that most of the mutants
failed to form particles and in most cases structures with been used to generate a panel of chimeric L1 proteins.
We found insertions of up to 50 amino acids not to inter-altered morphology were assembled. The results sug-
gested that most of the L1 sequences deleted were criti- fere with the efficiency of capsid formation. However,
exchange for 100 amino acids abolished capsid forma-cal for stability or correct formation of the capsid.
We sequenced all 23 L1 clones plus wild-type L1. We tion, yet allowed aberrant capsids to be formed (data not
shown).found a total of 14 point mutations in 9 of the L1 clones
(see Table 2). Six of the 9 clones had 1 point mutation, DC2 forms VLPs efficiently and maintains the capsid
conformation required for interaction with the receptor1 had 2 point mutations (one of which was silent), and
2 had 3 point mutations. Insertion of the two amino acids on mouse red blood cells. Therefore we assume that
they also retained the antigenic properties, although weAsp and Ile by the EcoRV restriction site was confirmed
at correct positions of the mutant L1 ORF. The sequence have not yet tested these VLPs for their capability to
generate neutralizing antibodies to BPV. DC2 can alsodata show that the point mutations introduced by PCR
were randomly distributed throughout the L1 ORF. Judg- tolerate insertions of up to 50 amino acids of the HPV-16
E7 protein and still form VLPs. HPV-16 L1 with a similar C-ing by DC2’s ability to form VLPs, it is likely that the
point mutations seen inDC2 do not interfere with particle terminal deletion has also been used for the insertion of
HPV-16 E7 sequences. These chimeric L1 proteins stillformation. The same conclusion, however, cannot be
drawn for the other L1 clones since they have point muta- formed VLPs (unpublished observations), and may be
candidates for the generation of therapeutic vaccinestions in different positions. In order to rule out the possi-
bility that the point mutations at nt 1453 of D1 through against HPV-related diseases.
D21 (Table 2 and Fig. 1) disrupted the capsid formation,
we examined capability of capsid formation from a BPV
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